$47.91 -0.58 (-1.20%)
2/10/2012 4:02 PM

Valeant Pharmaceuticals International (NYSE:VRX)

CAPS Rating: 3 out of 5

A global specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products, primarily in the areas of neurology, infectious disease, and dermatology.

Results 1 - 18 of 18

Recs

0
Member Avatar eksummers620 (73.32) Submitted: 12/29/2011 9:29:52 PM : Outperform Start Price: $46.10 VRX Score: -2.69

This is principal holding of the Sequoia Fund.

Recs

0
Member Avatar Retire20150 (56.26) Submitted: 9/23/2011 10:26:10 PM : Outperform Start Price: $38.33 VRX Score: +7.76

Generics are en vogue.

Recs

0
Member Avatar TomFoolNC (97.39) Submitted: 9/18/2011 11:25:48 PM : Outperform Start Price: $41.13 VRX Score: +4.08

picks its spots, Bob Goldfarb

Recs

0
Member Avatar gatzbp (72.57) Submitted: 8/18/2011 1:26:05 PM : Outperform Start Price: $39.87 VRX Score: +2.81

I like picking up healthcare after this pullback. Good model of cost cutting which should work regardless of who is in power in the government.

Recs

0
Member Avatar GingerInOz (31.72) Submitted: 6/20/2011 12:01:30 AM : Outperform Start Price: $50.42 VRX Score: -10.74

This company has pharmaceuticals in the pipeline that are already making the medical community enticed and waiting for FDA approval. Its performance thus far has been stellar.

Recs

0
Member Avatar LordDividend (< 20) Submitted: 5/4/2011 10:59:34 AM : Outperform Start Price: $48.69 VRX Score: -1.27

Who will the CEO target next?

Recs

0
Member Avatar thunderhawke23 (34.44) Submitted: 3/30/2011 10:17:51 AM : Outperform Start Price: $48.84 VRX Score: -3.31

strong CEO

Recs

0
Member Avatar outsidernone (< 20) Submitted: 12/1/2010 3:02:15 PM : Outperform Start Price: $26.97 VRX Score: +66.69

Approval of new drug

Recs

0
Member Avatar jsgant13 (96.11) Submitted: 11/15/2010 12:39:38 PM : Outperform Start Price: $25.17 VRX Score: +79.19

VALUEACT HOLDING

Recs

0
Member Avatar PilotF22 (81.13) Submitted: 9/30/2010 11:42:12 AM : Outperform Start Price: $24.00 VRX Score: +81.89

sg

Recs

0
Member Avatar up82870 (< 20) Submitted: 9/26/2010 2:33:44 PM : Outperform Start Price: $25.94 VRX Score: +67.73

They are being honest!

Recs

0
Member Avatar rathrbsrfng (51.97) Submitted: 5/17/2010 10:31:28 AM : Outperform Start Price: $18.67 VRX Score: +138.73

Good momentum

Recs

0
Member Avatar BSHumphreyII (88.44) Submitted: 4/28/2010 10:55:00 PM : Outperform Start Price: $17.33 VRX Score: +164.63

Valeant is a high-momentum growth pick. They've had monster EPS growth in the past, but that has slowed somewhat. Sales growth is steady in the low 30s, though. Their new anti-epilepsy drug Retigabine is moving through the pipeline and has the potential to be a huge winner.

There's some serious risk with the potential reward though, so be careful. Valeant aggressive acquisition strategy could be spreading them thin, and they're using significantly more leverage than their competitors in the process. One wrong step could make Valeant's sweet fundamentals turn sour in a hurry.

All said, though, VRX is a big growth story that is quickly moving up in the pharmaceutical world. It should be worth a buy, but stay on top of the news and do your homework.

Recs

0
Member Avatar mrbill6 (66.59) Submitted: 10/29/2009 8:16:43 PM : Outperform Start Price: $11.71 VRX Score: +282.58

moneycentral rated: 10, navallier rated:A

Recs

0
Member Avatar Beebzer (90.33) Submitted: 5/20/2009 1:34:09 AM : Outperform Start Price: $9.12 VRX Score: +377.48

Building a portfolio based on insider cluster buys.

Recs

1
Member Avatar crimfunk (81.60) Submitted: 2/2/2008 1:21:34 AM : Outperform Start Price: $4.38 VRX Score: +993.60

undervalued, EPS 5 Year Growth (%) 199.82

Recs

0
Member Avatar hennessy7 (< 20) Submitted: 10/10/2007 11:27:13 AM : Outperform Start Price: $6.19 VRX Score: +683.32

I was long on this stock until my stop loss triggered. Looks like it may trend down before coming back up. Not willing to bet my $ but I will put it on CAPS.

Recs

0
Member Avatar henncoop (98.12) Submitted: 5/16/2007 1:30:17 PM : Outperform Start Price: $6.20 VRX Score: +678.87

near 52 week low

Results 1 - 18 of 18

Featured Broker Partners


Advertisement